Explore who we are
Walk into Hengrui
Est.
1970
New Molecular Entity drugs marketed in China
24
Other innovative drugs marketed in China
4
SH 600276
HK 1276
Est.
1970
Marketed Innovative Products in China
8
Partnered Innovative Product Launched
1
SH 600276
HK 1276
Investor
Enhance communication between our company and investors

Media
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
Media
Hengrui Pharma and Braveheart Bio Enter Exclusive License Agreement for Cardiac Myosin Inhibitor HRS-1893
Media